Prostate-specific antigen (PSA) blood testing likely reduces the risk of death from prostate cancer, found a new review ...
A major review of nearly 800,000 men has found prostate cancer screening using a specific test is likely to reduce deaths ...
The understanding of prostate cancer has significantly evolved in the past 15 years. However, many people—including primary care providers—may not be aware of the current guidelines for prostate ...
A new study suggests that prostate cancer screening could reduce deaths by 13 per cent, as cancer experts in the UK assess ...
This article was reviewed by Darragh O’Carroll, MD. Prostate-specific antigen (PSA) is a term you’ll probably become familiar with once you start getting screened regularly for prostate cancer ...
A new blood test could help doctors identify whether a treatment for advanced prostate cancer is failing weeks earlier than ...
Clinical study design and research outcomes. (Bottom left) Low dose abiraterone acetate (AA) demonstrated reduced PSA levels-a marker of tumour activity. (Bottom middle) Safety profile suggested that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results